The Challenge
Founded in 2011, Ablative Solutions, Inc. is a venture-backed company that developed I.P. for a Renal Denervation Device, but with limited resources and the need to move quickly, they came to REV·1 for the development of their combination product.
The Solution
REV·1 initiated the engagement in November, 2011, with the development of a project plan to bring the device to clinical trials. REV·1 was charged with managing all aspects of the development of the Peregrine System™ Infusion Catheter.
“I outsource everything. So character is critical to me. When we decided REV.1 was our partner, they started the very next day, and every day they put skin in the game. They owned our project like it was theirs, they aren’t a fair-weather outsourcing company, they are always available and always listening. Their high-quality work and ability to problem-solve allowed us to get our life-saving product market-ready faster than we originally projected.”